Cargando…
Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis
Silicosis is an occupational lung disease for which no effective therapy exists. We hypothesized that bosutinib, a tyrosine kinase inhibitor, might ameliorate inflammatory responses, attenuate pulmonary fibrosis, and thus improve lung function in experimental silicosis. For this purpose, we investig...
Autores principales: | Carneiro, Priscila J., Clevelario, Amanda L., Padilha, Gisele A., Silva, Johnatas D., Kitoko, Jamil Z., Olsen, Priscilla C., Capelozzi, Vera L., Rocco, Patricia R. M., Cruz, Fernanda F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350127/ https://www.ncbi.nlm.nih.gov/pubmed/28360865 http://dx.doi.org/10.3389/fphys.2017.00159 |
Ejemplares similares
-
Therapeutic effects of bone marrow-derived mononuclear cells from healthy or silicotic donors on recipient silicosis mice
por: de Oliveira, Helena D’Anunciação, et al.
Publicado: (2017) -
Variable Ventilation Improved Respiratory System Mechanics and Ameliorated Pulmonary Damage in a Rat Model of Lung Ischemia-Reperfusion
por: Soluri-Martins, André, et al.
Publicado: (2017) -
Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis
por: Cruz, Fernanda Ferreira, et al.
Publicado: (2016) -
Endotoxin-Induced Emphysema Exacerbation: A Novel Model of Chronic Obstructive Pulmonary Disease Exacerbations Causing Cardiopulmonary Impairment and Diaphragm Dysfunction
por: de Oliveira, Milena Vasconcellos, et al.
Publicado: (2019) -
Bosutinib for Chronic Myeloid Leukemia
por: Breccia, Massimo, et al.
Publicado: (2015)